TrialJournal of the American Geriatrics Society2022

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey.

Michael J DiStefano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.